CAS: 210891-04-6 - N-({2'-[(4,5-dimethyl-1,2-oxazol-3-yl)sulfamoyl]-4-(1,3-oxazol-2-yl)biphenyl-2-yl}methyl)-N,3,3-trimethylbutanamide
Fórmula:C28H32N4O5S
InChI:InChI=1/C28H32N4O5S/c1-18-19(2)37-30-26(18)31-38(34,35)24-10-8-7-9-23(24)22-12-11-20(27-29-13-14-36-27)15-21(22)17-32(6)25(33)16-28(3,4)5/h7-15H,16-17H2,1-6H3,(H,30,31)
- Sinónimos:
- butanamide, N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethyl-
- N-((2'-(((4,5-dimethyl-3-isoxazolyl)amino)sulfonyl)-4-(2-oxazolyl)(1,1'-biphenyl)-2-yl)methyl)-N,3,3-trimethylbutanamide
Butanamide, N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethyl-
CAS:210891-04-6
Fórmula:
C28H32N4O5S
Peso molecular:
536.6425
Ref: IN-DA002L19
1mg | A consultar | ||
5mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 26 de Noviembre de 2024
Edonentan
CAS:210891-04-6
Edonentan is a drug that belongs to the group of endothelin receptor antagonists. It has …
Fórmula:
C28H32N4O5S
Pureza:
Min. 95%
Peso molecular:
536.64 g/mol
Ref: 3D-FE29946
1mg | A consultar | ||
2mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
Edonentan
CAS:210891-04-6
Edonentan is A potent endothelin A (ETA) receptor antagonist that can be used to study …
Fórmula:
C28H32N4O5S
Pureza:
98.78% - 99%
Forma y color:
Solid
Peso molecular:
536.64
Ref: TM-T31605
1mg | 939,00 € | ||
5mg | 1.850,00 € | ||
25mg | 2.404,00 € | ||
50mg | 2.784,00 € | ||
100mg | 3.737,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025